Skip to content

The clinical application translational research of novel gastric ultrasound technology in the early-stage diagnosis and treatment of gastric cancer

The clinical application translational research of novel gastric ultrasound technology in the early-stage diagnosis and treatment of gastric cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400083638
Enrollment
Unknown
Registered
2024-04-29
Start date
2024-05-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

Gastroscopy combined with ultrasound:Gastroscopy combined with gastric contrast-enhanced ultrasound.
CT combined with ultrasound:CT examination combined with gastric contrast-enhanced ultrasound.

Sponsors

Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ? Screening patient population: patients with gastric cancer risk factors such as Helicobacter pylori infection, precancerous lesions, genetic factors, EB virus infection, long-term smoking and alcohol abuse, and doctors consider the need for gastric cancer-related screening; ? Patients with gastric cancer: a histological diagnosis of gastric cancer; ? Good compliance, can comply with the implementation of the study during the inspection and treatment programs; ? Informed this study and signed informed consent.

Exclusion criteria

Exclusion criteria: ? Patients with upper gastrointestinal perforation, upper gastrointestinal active bleeding and other contraindications of gastric ultrasonography; ? Patients with contraindications to gastroscopy; ? Patients with contraindications to CT examination; ? Patients with poor compliance, or uncontrolled epilepsy, central nervous system diseases or mental disorders, who could not cooperate or refused to complete the relevant examination and treatment; ? Refused to sign the informed consent.

Design outcomes

Primary

MeasureTime frame
gastric contrast-enhanced ultrasound report: including the properties of the gastric tumor (location, size, etc.) assessment and preoperative T staging evaluation of gastric cancer;

Secondary

MeasureTime frame
Gastroscopy report: the properties of the gastric tumor (location, size, etc.) assessment;CT report: preoperative T staging evaluation of gastric cancer;

Countries

China

Contacts

Public ContactWeiming Kang

Peking Union Medical College Hospital

pumchkangweiming@126.com+86 138 1097 9989

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026